Morphine and breast tumor metastasis: The role of matrix-degrading enzymes

Clinical and Experimental Metastasis

Volumn 31, Issue 2, 2014, Pages 149-158

  Afsharimani, Banafsheh ^a   Baran, Joanne ^b   Watanabe, Satoshi ^b,d   Lindner, Daniel ^b   Cabot, Peter J ^a   Parat, Marie Odile ^a,b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b LERNER RESEARCH INSTITUTE   (United States)

^c OUTCOMES RESEARCH CONSORTIUM   (United States)

^d NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Breast cancer; Endothelial cells; Macrophages; Matrix metalloproteinase 9; Morphine; Urokinase plasminogen activator

Indexed keywords

GELATINASE B; MORPHINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST METASTASIS; BREAST TUMOR; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; LUNG; MACROPHAGE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN DEGRADATION; TUMOR MICROENVIRONMENT;

ANIMALS; BREAST NEOPLASMS; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR MATRIX; FEMALE; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; MICE; MORPHINE; PROTEOLYSIS; TUMOR CELLS, CULTURED; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84893306949     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9616-3     Document Type: Article

References (41)

1. Afsharimani B, Cabot PJ, Parat MO (2011) Morphine use in cancer surgery. Front Pharmacol 2:46
2. Afsharimani B, Cabot P, Parat MO (2011) Morphine and tumor growth and metastasis. Cancer Metastasis Rev 30:225-238
3. Gach K, Wyrebska A, Fichna J, Janecka A (2011) The role of morphine in regulation of cancer cell growth. Naunyn Schmiedebergs Arch Pharmacol 384:221-230
4. Eckhardt BL, Francis PA, Parker BS, Anderson RL (2012) Strategies for the discovery and development of therapies for metastatic breast cancer. Nat Rev Drug Discov 11:479-497
5. Kest B, Palmese CA, Hopkins E, Adler M, Juni A (2001) Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol Biochem Behav 70:149-156
6. Liang DY, Guo T, Liao G, Kingery WS, Peltz G, Clark JD (2006) Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence. Pain 121:232-240
7. Ognibene E, Adriani W, Granstrem O, Pieretti S, Laviola G (2007) Impulsivity-anxiety-related behavior and profiles of morphine-induced analgesia in heterozygous reeler mice. Brain Res 1131:173-180
8. Handal M, Grung M, Skurtveit S, Ripel A, Morland J (2002) Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity. Pharmacol Biochem Behav 73:883-892
9. Diaz SL, Hermida MP, Joannas LD, Olivera M, Ridolfi A, Villaamil EC, Balerio GN (2007) Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice. Biopharm Drug Dispos 28:283-289
10. Page GG, Ben-Eliyahu S, Yirmiya R, Liebeskind JC (1993) Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 54:21-28
11. Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, Song CW, Gupta K (2007) COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 97:1523-1531
12. Shanahan H, Parat MO, Buggy DJ (2013) Could opioids affect cancer recurrence or metastases? Current experimental and Translational Evidence. In: Parat MO (ed) Morphine and metastasis. Springer, Dordrecht, pp 79-94
13. Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D, Hebbel RP (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62:4491-4498
14. Ishikawa M, Tanno K, Kamo A, Takayanagi Y, Sasaki K (1993) Enhancement of tumor growth by morphine and its possible mechanism in mice. Biol Pharm Bull 16:762-766
15. Yeager MP, Colacchio TA (1991) Effect of morphine on growth of metastatic colon cancer in vivo. Arch Surg 126:454-456
16. Lennon FE, Singleton PA (2013) Opioid regulation of vascular integrity. In: Parat MO (ed) Morphine and metastasis. Springer, Dordrecht, pp 47-61
17. Koodie L, Ramakrishnan S, Roy S (2010) Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol 177:984-997
18. Sasamura T, Nakamura S, Iida Y, Fujii H, Murata J, Saiki I, Nojima H, Kuraishi Y (2002) Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur J Pharmacol 441:185-191
19. Parat MO (2013) Morphine and metastasis: from bench to bedside. In: Parat MO (ed) Morphine and metastasis. Springer, Dordrecht, pp 1-13
20. Ustun F, Durmus-Altun G, Altaner S, Tuncbilek N, Uzal C, Berkarda S (2011) Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model. EATC, Med Oncol 28(4):1264-1272
21. Page GG, McDonald JS, Ben-Eliyahu S (1998) Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth 81:216-223
22. Hakim TS, Grunstein MM, Michel RP (1992) Opiate action in the pulmonary circulation. Pulm Pharmacol 5:159-165
23. Kim EJ, Shin M, Park H, Hong JE, Shin HK, Kim J, Kwon DY, Park JH (2009) Oral administration of 3,3′-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. J Nutr 139:2373-2379
24. Colombi M, Rebessi L, Boiocchi M, Barlati S (1986) Relationship between circulating plasminogen activators and tumor development in mice. Cancer Res 46:5748-5753
25. Melani C, Sangaletti S, Barazzetta FM, Werb Z, Colombo MP (2007) Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res 67:11438-11446
26. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239-252
27. Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, Binder C (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25:1543-1549
28. Tjiu JW, Chen JS, Shun CT, Lin SJ, Liao YH, Chu CY, Tsai TF, Chiu HC, Dai YS, Inoue H, Yang PC, Kuo ML, Jee SH (2008) Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol 129:1016-1025
29. Aoudjit F, Potworowski EF, St-Pierre Y (1998) Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. J Immunol 160:2967-2973
30. Serrati S, Margheri F, Fibbi G, Di Cara G, Minafra L, Pucci-Minafra I, Liotta F, Annunziato F, Pucci M, Del Rosso M (2008) Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. J Pathol 214:545-554
31. Kargozaran H, Yuan S, Breslin J, Watson K, Gaudreault N, Breen A, Wu M (2007) A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier. Clin Exp Metastasis 24:495-502
32. Neiva KG, Zhang Z, Miyazawa M, Warner KA, Karl E, Nor JE (2009) Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia 11:583-593
33. Ingthorsson S, Sigurdsson V, Fridriksdottir A Jr, Jonasson JG, Kjartansson J, Magnusson MK, Gudjonsson T (2010) Endothelial cells stimulate growth of normal and cancerous breast epithelial cells in 3D culture. BMC Res Notes 3:184
34. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR (2005) Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 175:1197-1205
35. Harimaya Y, Koizumi K, Andoh T, Nojima H, Kuraishi Y, Saiki I (2002) Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Lett 187:121-127
36. Nylund G, Pettersson A, Bengtsson C, Khorram-Manesh A, Nordgren S, Delbro DS (2008) Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Dig Dis Sci 53:461-466
37. Gach K, Szemraj J, Wyrebska A, Janecka A. The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line. Mol Biol Rep 2010
38. Gach K, Szemraj J, Fichna J, Piestrzeniewicz M, Delbro DS, Janecka A (2009) The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line. Chem Biol Drug Des 74:390-396
39. Lin CW, Shen SC, Ko CH, Lin HY, Chen YC (2010) Reciprocal activation of macrophages and breast carcinoma cells by nitric oxide and colony-stimulating factor-1. Carcinogenesis 31:2039-2048
40. Sarkar DK, Murugan S, Zhang C, Boyadjieva N (2012) Regulation of cancer progression by +/-endorphin neuron. Cancer Res 72:836-840
41. Kawata M, Koinuma D, Ogami T, Umezawa K, Iwata C, Watabe T, Miyazono K (2012) TGF-+/ - induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells. J Biochem 151:205-216